002932 明德生物
已收盘 05-13 15:00:00
资讯
新帖
简况
明德生物:公司暂未涉及合成生物领域
证券之星 · 05-08
明德生物:公司暂未涉及合成生物领域
【企业动态】明德生物新增1件法院诉讼,案由为合同纠纷
证券之星 · 05-08
【企业动态】明德生物新增1件法院诉讼,案由为合同纠纷
明德生物(002932.SZ)已耗资7516.75万元回购1.60%股份
智通财经网 · 05-06
明德生物(002932.SZ)已耗资7516.75万元回购1.60%股份
图解明德生物一季报:第一季度单季净利润同比减57.52%
证券之星 · 04-29
图解明德生物一季报:第一季度单季净利润同比减57.52%
明德生物(002932.SZ)发一季度业绩,净利润3205.21万元,同比减少57.52%
智通财经 · 04-29
明德生物(002932.SZ)发一季度业绩,净利润3205.21万元,同比减少57.52%
大手笔!46亿市值的明德生物拟使用不超40亿元购买理财产品
证券之星 · 04-25
大手笔!46亿市值的明德生物拟使用不超40亿元购买理财产品
明德生物(002932.SZ)发2023年度业绩,净利润7492.59万元,同比减少98.22%
智通财经 · 04-25
明德生物(002932.SZ)发2023年度业绩,净利润7492.59万元,同比减少98.22%
明德生物拟使用不超40亿元购买理财产品 截至收盘公司总市值46亿元
证券之星 · 04-25
明德生物拟使用不超40亿元购买理财产品 截至收盘公司总市值46亿元
器械股再度组团冲高,医疗器械指数ETF(159898)大涨3.18%冲击四连阳!热景生物、明德生物多股封涨停
新浪基金 · 02-08
器械股再度组团冲高,医疗器械指数ETF(159898)大涨3.18%冲击四连阳!热景生物、明德生物多股封涨停
明德生物(002932.SZ)发预减,预计净利润5500万元—7500万元 大幅下降98.22%至98.69%
智通财经网 · 01-30
明德生物(002932.SZ)发预减,预计净利润5500万元—7500万元 大幅下降98.22%至98.69%
加载更多
公司概况
公司名称:
武汉明德生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2018-07-10
主营业务:
武汉明德生物科技股份有限公司主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司的主要产品及服务为免疫层析技术平台、免疫荧光技术平台、化学发光技术平台、病原体核酸检测产品、药物代谢基因检测产品、一体式湿式血气分析仪、全自动凝血分析仪、急危重症信息化解决方案、第三方医学检验。2022年12月,在中国心血管健康大会上,采用公司信息化解决方案的湖北省英山县人民医院荣获智慧胸痛中心建设最佳解决方案金奖,成为全国唯一一家荣获智慧胸痛中心建设最佳解决方案金奖的县级医院。
发行价格:
20.45
{"stockData":{"symbol":"002932","market":"SZ","secType":"STK","nameCN":"明德生物","latestPrice":20.29,"timestamp":1715583819000,"preClose":20.74,"halted":0,"volume":3541239,"delay":0,"floatShares":156000000,"shares":233000000,"eps":0.1356,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.45,"latestTime":"05-13 15:00:00","open":20.85,"high":20.85,"low":20.2,"amount":72116500,"amplitude":0.0313,"askPrice":20.3,"askSize":2,"bidPrice":20.29,"bidSize":146,"shortable":0,"etf":0,"ttmEps":0.1356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715650200000},"adr":0,"adjPreClose":20.74,"symbolType":"stock","openAndCloseTimeList":[[1715563800000,1715571000000],[1715576400000,1715583600000]],"highLimit":22.81,"lowLimit":18.67,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":232520957,"pbRate":0.8,"roa":"--","roe":"0.53%","epsLYR":0.33,"committee":0.630631,"marketValue":4718000000,"floatMarketCap":3167000000,"peRate":149.631268,"changeRate":-0.0217,"turnoverRate":0.0227,"status":1},"requestUrl":"/m/hq/s/002932","defaultTab":"news","newsList":[{"id":"2433411767","title":"明德生物:公司暂未涉及合成生物领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2433411767","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433411767?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:01","pubTimestamp":1715166075,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物05月08日在投资者关系平台上答复投资者关心的问题。投资者:2022年贵公司与北京君远,君联和泰,康哲创业共同投资的合成生物项目进展如何了?本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800034019.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433753036","title":"【企业动态】明德生物新增1件法院诉讼,案由为合同纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2433753036","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433753036?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:32","pubTimestamp":1715117575,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,4月29日明德生物(002932)新增1件法院诉讼如下:案号:(2024)鄂0192民初6660号法院:武汉东湖新技术开发区人民法院案由:合同纠纷原告:郑州市柘丘特技术服务有限公司被告:深圳市铭辰自动化科技有限公司、武汉明德生物科技股份有限公司案件类型:民事立案日期:2024年4月29日数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800007893.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433644727","title":"明德生物(002932.SZ)已耗资7516.75万元回购1.60%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433644727","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2433644727?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:11","pubTimestamp":1714990308,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,截止到2024年4月30日,公司通过回购专用证券账户以集中竞价方式回购公司股份372.96万股,占公司总股本的1.60%;回购股份最高成交价为20.98元/股,最低成交价为19.3元/股,总成交金额为人民币7516.75万元(不含交易税费)。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117658.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431353880","title":"图解明德生物一季报:第一季度单季净利润同比减57.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431353880","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431353880?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:44","pubTimestamp":1714383899,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物2024年一季报显示,公司主营收入6096.34万元,同比下降83.63%;归母净利润3205.21万元,同比下降57.52%;扣非净利润-1597.06万元,同比下降133.22%;负债率12.88%,投资收益2685.69万元,财务费用-262.72万元,毛利率40.28%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900023014.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431275885","title":"明德生物(002932.SZ)发一季度业绩,净利润3205.21万元,同比减少57.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431275885","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431275885?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:57","pubTimestamp":1714381066,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布2024年第一季度报告,报告期内公司实现营业收入6096.34万元,同比减少83.63%;归属于上市公司股东的净利润3205.21万元,同比减少57.52%;归属于上市公司股东扣除非经常性损益净亏损1597.06万元;基本每股收益0.14元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114254.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430178281","title":"大手笔!46亿市值的明德生物拟使用不超40亿元购买理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2430178281","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430178281?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:51","pubTimestamp":1714053117,"startTime":"0","endTime":"0","summary":"4月25日晚,明德生物发布公告宣布,公司及其下属公司计划使用总计不超过40亿元人民币的闲置自有资金进行委托理财,购买低风险理财产品。值得注意的是,截至4月25日收盘,明德生物股价报收19.91元,总市值46.29亿。针对投资风险方面,明德生物也直言,以上额度内资金只能购买不超过十二个月低风险理财产品,不得用于证券投资,不得购买除低风险金融理财产品以外的其他理财产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024042500045957.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430447027","title":"明德生物(002932.SZ)发2023年度业绩,净利润7492.59万元,同比减少98.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430447027","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430447027?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:43","pubTimestamp":1714041822,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布2023年年度报告,营业收入7.5亿元,同比减少92.88%。归属于上市公司股东的净利润7492.59万元,同比减少98.22%。公司股东的扣除非经常性损益的净亏损1.24亿元,基本每股收益0.33元,向全体股东每10股派发现金红利1.20元(含税),不送红股,不以公积金转增股本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110206.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430574472","title":"明德生物拟使用不超40亿元购买理财产品 截至收盘公司总市值46亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430574472","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430574472?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:10","pubTimestamp":1714039825,"startTime":"0","endTime":"0","summary":"明德生物公告,公司及公司各下属公司合计拟使用不超过人民币40亿元的闲置自有资金购买低风险的理财产品。同日公告,公司拟于2024年半年度或三季度结合当期净利润进行现金分红,以公司总股本扣除利润分配方案实施时股权登记日公司回购专户上已回购股份后的总股本为基数,派发现金红利。注:截至收盘,明德生物总市值为46亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500038983.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2409312617","title":"器械股再度组团冲高,医疗器械指数ETF(159898)大涨3.18%冲击四连阳!热景生物、明德生物多股封涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2409312617","media":"新浪基金","top":-1,"share":"https://www.laohu8.com/m/news/2409312617?lang=zh_cn&edition=full","pubTime":"2024-02-08 10:20","pubTimestamp":1707358800,"startTime":"0","endTime":"0","summary":"2月8日开盘,医疗器械板块热度不减,个股层面轮番上攻,明德生物、振德医疗10CM涨停,热景生物20CM涨停,麦澜徳、万孚生物、诺唯赞、赛诺医疗、奥美医疗、万东医疗等股涨幅均超8个点。 场内热门ETF方面,聚焦医疗器械细分板块的医疗器械指数ETF早盘快速拉升,截至发文涨幅3.18%,日K线冲击四连阳。本周以来,医疗器械指数ETF标的指数底部强势反弹,区间累计涨幅已超13%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/etf/2024-02-08/doc-inahhsyr1870951.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-02-08/doc-inahhsyr1870951.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2407332581","title":"明德生物(002932.SZ)发预减,预计净利润5500万元—7500万元 大幅下降98.22%至98.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407332581","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2407332581?lang=zh_cn&edition=full","pubTime":"2024-01-30 19:29","pubTimestamp":1706614140,"startTime":"0","endTime":"0","summary":"明德生物(002932.SZ)发布2023年年度业绩预告,预计全年归属于上市公司股东的净利润5500万元—7500万元,同比下降98.22%至98.69%。主要原因系:(1)公司营业收入下降,导致公司净利润大幅下滑;(2)终端客户回款困难,信用风险增加,对部分高风险客户计提坏账准备;(3)过去三年产能持续扩张后导致公司固定资产金额较大,从而导致折旧费用较高。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafiecf6785644.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafiecf6785644.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-07-10","address":"湖北省武汉市江夏区东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器3.1期25栋1层(3)厂房三号","stockEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0903},{"period":"6month","weight":-0.1684},{"period":"1year","weight":-0.2863},{"period":"ytd","weight":-0.1167}],"companyName":"武汉明德生物科技股份有限公司","boardCode":"AI0027","perCapita":"4393股","boardName":"医药制造业","registeredCapital":"23252万元","compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":0.0426},{"period":"3month","weight":0.0984},{"period":"6month","weight":0.0245},{"period":"1year","weight":-0.038},{"period":"ytd","weight":0.0582}],"survey":" 武汉明德生物科技股份有限公司主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司的主要产品及服务为免疫层析技术平台、免疫荧光技术平台、化学发光技术平台、病原体核酸检测产品、药物代谢基因检测产品、一体式湿式血气分析仪、全自动凝血分析仪、急危重症信息化解决方案、第三方医学检验。2022年12月,在中国心血管健康大会上,采用公司信息化解决方案的湖北省英山县人民医院荣获智慧胸痛中心建设最佳解决方案金奖,成为全国唯一一家荣获智慧胸痛中心建设最佳解决方案金奖的县级医院。","serverTime":1715618012046,"listedPrice":20.45,"stockholders":"35526人(较上一季度减少1.51%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"明德生物,002932,明德生物股票,明德生物股票老虎,明德生物股票老虎国际,明德生物行情,明德生物股票行情,明德生物股价,明德生物股市,明德生物股票价格,明德生物股票交易,明德生物股票购买,明德生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}